205 related articles for article (PubMed ID: 3925935)
1. Apo E-containing lipoproteins in low or high density lipoprotein deficiency.
Gibson JC; Rubinstein A; Brown WV; Ginsberg HN; Greten H; Norum R; Kayden H
Arteriosclerosis; 1985; 5(4):371-80. PubMed ID: 3925935
[TBL] [Abstract][Full Text] [Related]
2. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.
Forte TM; Nichols AV; Krauss RM; Norum RA
J Clin Invest; 1984 Nov; 74(5):1601-13. PubMed ID: 6501564
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
4. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
5. Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma.
Innerarity TL; Bersot TP; Arnold KS; Weisgraber KH; Davis PA; Forte TM; Mahley RW
Metabolism; 1984 Feb; 33(2):186-95. PubMed ID: 6319954
[TBL] [Abstract][Full Text] [Related]
6. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and secretion of lipoproteins by human hepatocytes in culture.
Bouma ME; Pessah M; Renaud G; Amit N; Catala D; Infante R
In Vitro Cell Dev Biol; 1988 Feb; 24(2):85-90. PubMed ID: 3125144
[TBL] [Abstract][Full Text] [Related]
8. Familial apolipoprotein A-I and C-III deficiency, variant II.
Schaefer EJ; Ordovas JM; Law SW; Ghiselli G; Kashyap ML; Srivastava LS; Heaton WH; Albers JJ; Connor WE; Lindgren FT
J Lipid Res; 1985 Sep; 26(9):1089-101. PubMed ID: 3934306
[TBL] [Abstract][Full Text] [Related]
9. Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients.
von Eckardstein A; Huang Y; Kastelein JJ; Geisel J; Real JT; Kuivenhoven JA; Miccoli R; Noseda G; Assmann G
Atherosclerosis; 1998 May; 138(1):25-34. PubMed ID: 9678768
[TBL] [Abstract][Full Text] [Related]
10. Changes in the distribution and composition of high-density lipoproteins in primary hypothyroidism.
Muls E; Rosseneu M; Lamberigts G; De Moor P
Metabolism; 1985 Apr; 34(4):345-53. PubMed ID: 3920475
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of gemfibrozil on lipoprotein metabolism.
Saku K; Gartside PS; Hynd BA; Kashyap ML
J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis.
Huff MW; Breckenridge WC; Strong WL; Wolfe BM
Arteriosclerosis; 1988; 8(5):471-9. PubMed ID: 3190554
[TBL] [Abstract][Full Text] [Related]
14. Familial hypoalphalipoproteinemias.
Frohlich J; Westerlund J; Sparks D; Pritchard PH
Clin Invest Med; 1990 Aug; 13(4):202-10. PubMed ID: 2119926
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia.
Gibson JC; Goldberg RB; Rubinstein A; Ginsberg HN; Brown WV; Baker S; Joffe BI; Seftel HC
Arteriosclerosis; 1987; 7(4):401-7. PubMed ID: 3606467
[TBL] [Abstract][Full Text] [Related]
16. Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).
Alaupovic P; Schaefer EJ; McConathy WJ; Fesmire JD; Brewer HB
Metabolism; 1981 Aug; 30(8):805-9. PubMed ID: 6790903
[TBL] [Abstract][Full Text] [Related]
17. Two patterns of LDL metabolism in normotriglyceridemic patients with hypoalphalipoproteinemia.
Vega GL; Grundy SM
Arterioscler Thromb; 1993 Apr; 13(4):579-89. PubMed ID: 8466893
[TBL] [Abstract][Full Text] [Related]
18. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
[TBL] [Abstract][Full Text] [Related]
19. Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia.
Blum CB; Deckelbaum RJ; Witte LD; Tall AR; Cornicelli J
J Clin Invest; 1982 Dec; 70(6):1157-69. PubMed ID: 6294137
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
